Model of the RNA Polymerase Complex of the SARS-CoV-2 Virus with Favipiravir

被引:3
|
作者
Polyakov, I. V. [1 ,2 ]
Grigorenko, B. L. [1 ,2 ]
Nemukhin, A. V. [1 ,2 ]
机构
[1] Russian Acad Sci, Emanuel Inst Biochem Phys, Moscow 119991, Russia
[2] Moscow MV Lomonosov State Univ, Moscow 119991, Russia
基金
俄罗斯基础研究基金会;
关键词
molecular dynamics; coronavirus; RNA polymerase; reaction mechanism; inhibition; favipiravir;
D O I
10.1134/S1990793121010255
中图分类号
O64 [物理化学(理论化学)、化学物理学]; O56 [分子物理学、原子物理学];
学科分类号
070203 ; 070304 ; 081704 ; 1406 ;
摘要
A model of a multidomain complex is constructed using molecular modeling methods to explain the mechanism of the inhibitory effect of favipiravir on RNA-dependent RNA polymerase (RdRp) of the SARS-CoV-2 coronavirus. As the initial atomic coordinates, we use cryoelectron microscopy data for the apo form of RdRp of the SARS-CoV-2 virus and data on the structure of RdRp of the hepatitis C virus. After appropriate substitutions, an RdRp complex containing RNA chains and a potential enzyme inhibitor, favipiravir in the form of ribosatriphosphate, are constructed. The structure of the complex in aqueous shells, which includes more than 100 000 atoms, is optimized by molecular dynamics methods. Analysis of the active site with the incorporated favipiravir molecule makes it possible to explain the chemical reaction of the enzyme with the inhibitor.
引用
收藏
页码:103 / 107
页数:5
相关论文
共 50 条
  • [21] Piece of the puzzle: Remdesivir disassembles the multimeric SARS-CoV-2 RNA-dependent RNA polymerase complex
    Olotu, Fisayo A.
    Omolabi, Kehinde F.
    Soliman, Mahmoud E. S.
    CELL BIOCHEMISTRY AND BIOPHYSICS, 2021, 79 (02) : 175 - 187
  • [22] Remdesivir Inhibits SARS-CoV-2 in Human Lung Cells and Chimeric SARS-CoV Expressing the SARS-CoV-2 RNA Polymerase in Mice
    Pruijssers, Andrea J.
    George, Amelia S.
    Schafer, Alexandra
    Leist, Sarah R.
    Gralinksi, Lisa E.
    Dinnon, Kenneth H., III
    Yount, Boyd L.
    Agostini, Maria L.
    Stevens, Laura J.
    Chappell, James D.
    Lu, Xiaotao
    Hughes, Tia M.
    Gully, Kendra
    Martinez, David R.
    Brown, Ariane J.
    Graham, Rachel L.
    Perry, Jason K.
    Du Pont, Venice
    Pitts, Jared
    Ma, Bin
    Babusis, Darius
    Murakami, Eisuke
    Feng, Joy Y.
    Bilello, John P.
    Porter, Danielle P.
    Cihlar, Tomas
    Baric, Ralph S.
    Denison, Mark R.
    Sheahan, Timothy P.
    CELL REPORTS, 2020, 32 (03):
  • [23] Detailed Molecular Interactions of Favipiravir with SARS-CoV-2, SARS-CoV, MERS-CoV, and Influenza Virus Polymerases In Silico
    Sada, Mitsuru
    Saraya, Takeshi
    Ishii, Haruyuki
    Okayama, Kaori
    Hayashi, Yuriko
    Tsugawa, Takeshi
    Nishina, Atsuyoshi
    Murakami, Koichi
    Kuroda, Makoto
    Ryo, Akihide
    Kimura, Hirokazu
    MICROORGANISMS, 2020, 8 (10) : 1 - 9
  • [24] Structural basis for inhibition of the SARS-CoV-2 RNA polymerase by suramin
    Yin, Wanchao
    Luan, Xiaodong
    Li, Zhihai
    Zhou, Ziwei
    Wang, Qingxing
    Gao, Minqi
    Wang, Xiaoxi
    Zhou, Fulai
    Shi, Jingjing
    You, Erli
    Liu, Mingliang
    Wang, Qingxia
    Jiang, Yi
    Jiang, Hualiang
    Xiao, Gengfu
    Zhang, Leike
    Yu, Xuekui
    Zhang, Shuyang
    Eric Xu, H.
    NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2021, 28 (03) : 319 - 325
  • [25] Sangivamycin is preferentially incorporated into viral RNA by the SARS-CoV-2 polymerase
    Bennett, Ryan P.
    Yoluc, Yasemin
    Salter, Jason D.
    Ripp, Alexander
    Jessen, Henning J.
    Kaiser, Stefanie M.
    Smith, Harold C.
    ANTIVIRAL RESEARCH, 2023, 218
  • [26] Structural basis for inhibition of the SARS-CoV-2 RNA polymerase by suramin
    Wanchao Yin
    Xiaodong Luan
    Zhihai Li
    Ziwei Zhou
    Qingxing Wang
    Minqi Gao
    Xiaoxi Wang
    Fulai Zhou
    Jingjing Shi
    Erli You
    Mingliang Liu
    Qingxia Wang
    Yi Jiang
    Hualiang Jiang
    Gengfu Xiao
    Leike Zhang
    Xuekui Yu
    Shuyang Zhang
    H. Eric Xu
    Nature Structural & Molecular Biology, 2021, 28 : 319 - 325
  • [27] Oral favipiravir for patients with delayed SARS-CoV-2 viral RNA clearance: a case series
    Fu, Dian
    Cao, Ruiyuan
    Zhao, Lei
    Li, Wei
    Zhong, Wu
    Wen, Jiqiu
    CRITICAL CARE, 2020, 24 (01)
  • [28] Oral favipiravir for patients with delayed SARS-CoV-2 viral RNA clearance: a case series
    Dian Fu
    Ruiyuan Cao
    Lei Zhao
    Wei Li
    Wu Zhong
    Jiqiu Wen
    Critical Care, 24
  • [29] Polyphenols as Potential Inhibitors of SARS-CoV-2 RNA Dependent RNA Polymerase (RdRp)
    Wu, Yifei
    Crich, David
    Pegan, Scott D.
    Lou, Lei
    Hansen, Madelyn C.
    Booth, Carson
    Desrochers, Ellison
    Mullininx, Lauren Nicole
    Starling, Edward B.
    Chang, Kuan Y.
    Xie, Zhong-Ru
    MOLECULES, 2021, 26 (24):
  • [30] Mechanism of reaction of RNA-dependent RNA polymerase from SARS-CoV-2
    Aranda, Juan
    Wieczor, Milosz
    Terrazas, Montserrat
    Brun-Heath, Isabelle
    Orozco, Modesto
    CHEM CATALYSIS, 2022, 2 (05): : 1084 - 1099